Question follow-through · 36557

Rare Diseases: Medical Treatments

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the proposed changes to National Institute for Health and Care Excellence Highly Specialised Technology (HST) routing criteria aligns with the stated aim of HST to

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
7 Mar 2025
Target answer date
11 Mar 2025
Answer
13 Mar 2025 · 6 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 7 Mar 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the proposed changes to National Institute for Health and Care Excellence Highly Specialised Technology (HST) routing criteria aligns with the stated aim of HST to

  2. 11 Mar 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 13 Mar 2025

    Answer published

    Decisions on whether medicines should be evaluated by the National Institute for Health and Care Excellence (NICE) through its highly specialised technologies (HST) programme are taken by NICE itself against a set of published criteria that have been deve...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Myasthenia Gravis: Medical Treatments

11 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps he has taken to increase patient access to new and innovative treatments for Myasthenia Gravis.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Myasthenia Gravis: Medical Treatments

11 Mar 2025 · To ask the Secretary of State for Health and Social Care, what his planned timetable is for when patients with Myasthenia Gravis will have access to recently licenced products.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Rare Diseases: Diagnosis and Medical Treatments

11 Mar 2025 · To ask the Secretary of State for Health and Social Care, whether the NHS 10 Year Plan will include steps to ensure healthcare professionals are adequately trained and supported in diagnosing and treating rare diseases like Myasthenia Gravis.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Care Homes: Drugs

30 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made on the adequacy of access to (a) medicines and (b) controlled drugs in care homes in North Somerset.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Care Homes: Drugs

30 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of regulation of access to controlled drugs in care homes in North Somerset.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services

12 May 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to include policies on self-care within the forthcoming 10-year Health Plan.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS England: Drugs

22 May 2025 · To ask the Secretary of State for Health and Social Care, how many commercial agreements NHS England has made with manufacturers of medicines which have r resulted in indication-specific pricing between January 2020 and March 2025; and what therapeutic ar

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Life Sciences

22 May 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s criterion for eligibility for indication-specific pricing to demonstrate revenue loss on the UK’s international competitiveness

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services

3 Jun 2025 · To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 16 May 2025 to Question 51728, what steps he is taking to ensure that patients (a) improve and (b) protect their own health.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Fees and Charges

3 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to prevent spoke pharmacies from charging patients for additional services which are delivered by an outsourced hub partner.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Nurses: Schools

10 Jun 2025 · To ask the Secretary of State for Health and Social Care, how many and what proportion of school nurses have received specialist training in (a) allergy and (b) anaphylaxis management.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Bladder Cancer: Health Services

23 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of care for bladder cancer in each region; and if he will hold discussions with NICE guidelines on the time taken to update its guidelines on